 The purpose of the study is to determine the appropriate dose of fluticasone propionateformoterol fumarate that is closest to Advair Diskus fluticasone propionatesalmeterol xinafoate using pulmonary function, safety, and levels of study drug in blood plasma in patients with chronic obstructive pulmonary disease. 